ASTRAZENECA CANADA: HEALTH CANADA GRANTED NOC FOR FASENRA AS ADD-ON TO STANDARD THERAPY FOR TREATMENT OF PATIENTS AGED 12 YRS & OLDER WITH HES

Reuters · 1d ago

Please log in to view news